Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03221 Zeteletinib
D12330 Zeteletinib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
RET family
RET
D12330 Zeteletinib (USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG03221 Zeteletinib
Other DBs
CAS:
2216753-97-6
LinkDB
KCF data
ATOM 36
1 C8y C 7.3500 -16.8700
2 C8y C 7.3500 -18.2700
3 C8x C 8.5624 -18.9700
4 C8y C 9.7749 -18.2700
5 C8y C 9.7749 -16.8700
6 C8x C 8.5624 -16.1700
7 C8x C 10.9873 -18.9700
8 C8y C 12.1997 -18.2700
9 C8x C 12.1997 -16.8700
10 N5x N 10.9873 -16.1700
11 O2a O 6.1376 -16.1700
12 C1a C 4.9421 -16.8604
13 O2a O 6.1376 -18.9700
14 C1a C 4.9421 -18.2796
15 C8y C 13.3973 -18.9615
16 C8x C 13.3973 -20.3697
17 C8x C 14.6098 -21.0697
18 C8y C 15.8222 -20.3697
19 C8x C 15.8222 -18.9615
20 N5x N 14.6097 -18.2615
21 C1b C 17.0331 -21.0688
22 C5a C 18.2276 -20.3790
23 N1b N 19.4155 -21.0647
24 O5a O 18.2276 -18.9703
25 C8y C 20.6071 -20.3733
26 C8x C 21.9250 -20.7586
27 C8y C 22.6987 -19.6243
28 N5x N 21.8590 -18.5379
29 O2x O 20.5663 -19.0008
30 C1d C 24.0648 -19.5830
31 C1d C 25.4648 -19.5830
32 C1a C 24.1141 -18.2005
33 C1a C 24.0860 -21.0000
34 X F 26.8648 -19.5830
35 X F 25.4648 -18.1830
36 X F 25.4648 -20.9830
BOND 39
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 1 11 1
13 11 12 1
14 2 13 1
15 13 14 1
16 8 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
24 21 22 1
25 22 23 1
26 22 24 2
27 23 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 28 29 1
32 25 29 1
33 27 30 1
34 30 31 1
35 30 32 1
36 30 33 1
37 31 34 1
38 31 35 1
39 31 36 1
